Characterization of amyloid-β granules in the hippocampus of SAMP8 mice

Gemma Manich1, Clara Mercader, Jaume del Valle

  • 1Departament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain.

Insights

Amyloid-beta (Aβ) granules in the senescence accelerated mouse-prone 8 (SAMP8) model contain tau and MAP2 proteins, suggesting a neuronal origin. These findings support the SAMP8 mouse as a model for studying neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Aging Research
  • Alzheimer's Disease Models

Background:

  • The senescence accelerated mouse-prone 8 (SAMP8) mouse strain exhibits accelerated aging and Alzheimer's disease (AD)-like features.
  • Previous studies identified amyloid-beta (Aβ) granules in the hippocampus of SAMP8 mice.

Purpose of the Study:

  • To investigate the presence of other neuropathological proteins (tau, MAP2, α-synuclein) within Aβ granules in SAMP8 mice.
  • To determine if Aβ granules correspond to previously described heparan sulphate proteoglycan (HSPG) positive granules.

Main Methods:

  • Immunohistochemical analysis of hippocampal tissue from SAMP8 mice.
  • Detection of Aβ, tau, MAP2, α-synuclein, and HSPG markers.
  • Examination of cellular origins (neuronal, astrocytic) of Aβ aggregates.

Main Results:

  • Aβ granules were confirmed to be HSPG-positive structures, specifically containing syndecan-2.
  • Tau and MAP2 proteins were found within Aβ aggregates, while α-synuclein was not.
  • Evidence suggests a neuronal origin for the Aβ granules, with some association with astrocyte processes.

Conclusions:

  • The Aβ granules in SAMP8 mice contain key proteins found in neurodegenerative disease aggregates.
  • The SAMP8 mouse model is suitable for investigating the mechanisms underlying neurodegenerative pathologies.

Related Concept Videos